Incannex Healthcare Inc.

IXHL ·Healthcare, Drug Manufacturers - General
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Assets
Cash & Equivalents $67.7M $15.0M $5.9M $22.1M $25.8M $9.1M $3.6M
Accounts Receivable — — — $287.5K $294.7K $169.1K $225.1K
Inventory — — — — — — —
Total Current Assets $72.8M $20.0M $16.2M $23.0M $37.9M $9.3M $4.2M
Property, Plant & Equipment $4.0K $227.0K $472.0K $294.0K — — —
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — —
Total Assets $73.0M $20.4M $17.0M $23.8M $37.9M $9.3M $4.2M
Liabilities
Accounts Payable $1.1M $6.1M $527.0K $1.7M $1.3M $233.1K $590.1K
Total Current Liabilities $1.5M $7.0M $5.6M $2.6M $2.0M $755.0K $1.1M
Long-Term Debt — — — — — — —
Total Liabilities $5.6M $7.1M $5.8M $3.0M $13.2M $755.0K $1.1M
Stockholders' Equity
Retained Earnings $-176.9M $-157.6M $-110.7M $-92.2M $-58.8M $-43.9M $-32.5M
Total Stockholders' Equity $67.4M $13.4M $11.2M $20.8M $24.7M $8.6M $3.2M